170 related articles for article (PubMed ID: 19037090)
1. Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.
Huang J; Chen K; Huang J; Gong W; Dunlop NM; Howard OM; Bian X; Gao Y; Wang JM
Carcinogenesis; 2009 Feb; 30(2):348-55. PubMed ID: 19037090
[TBL] [Abstract][Full Text] [Related]
2. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
[TBL] [Abstract][Full Text] [Related]
3. The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.
Huang J; Chen K; Chen J; Gong W; Dunlop NM; Howard OM; Gao Y; Bian XW; Wang JM
Br J Cancer; 2010 Mar; 102(6):1052-60. PubMed ID: 20197768
[TBL] [Abstract][Full Text] [Related]
4. Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
Yao XH; Ping YF; Chen JH; Chen DL; Xu CP; Zheng J; Wang JM; Bian XW
J Neurooncol; 2008 Jan; 86(1):47-53. PubMed ID: 17611713
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.
Huang J; Hu J; Bian X; Chen K; Gong W; Dunlop NM; Howard OM; Wang JM
Cancer Res; 2007 Jun; 67(12):5906-13. PubMed ID: 17575160
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines.
Kadowaki M; Yoshioka H; Kamitani H; Watanabe T; Wade PA; Eling TE
Int J Cancer; 2012 Jan; 130(2):267-77. PubMed ID: 21437897
[TBL] [Abstract][Full Text] [Related]
7. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
Karpf AR; Moore BC; Ririe TO; Jones DA
Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
[TBL] [Abstract][Full Text] [Related]
8. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
[TBL] [Abstract][Full Text] [Related]
9. Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1.
Yang Y; Liu Y; Yao X; Ping Y; Jiang T; Liu Q; Xu S; Huang J; Mou H; Gong W; Chen K; Bian X; Wang JM
Am J Pathol; 2011 Sep; 179(3):1504-12. PubMed ID: 21782780
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR.
Yao XH; Ping YF; Chen JH; Xu CP; Chen DL; Zhang R; Wang JM; Bian XW
J Pathol; 2008 Aug; 215(4):369-76. PubMed ID: 18523971
[TBL] [Abstract][Full Text] [Related]
11. 5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation.
Zhu WG; Hileman T; Ke Y; Wang P; Lu S; Duan W; Dai Z; Tong T; Villalona-Calero MA; Plass C; Otterson GA
J Biol Chem; 2004 Apr; 279(15):15161-6. PubMed ID: 14722112
[TBL] [Abstract][Full Text] [Related]
12. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
13. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
14. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.
Albertoni M; Shaw PH; Nozaki M; Godard S; Tenan M; Hamou MF; Fairlie DW; Breit SN; Paralkar VM; de Tribolet N; Van Meir EG; Hegi ME
Oncogene; 2002 Jun; 21(27):4212-9. PubMed ID: 12082608
[TBL] [Abstract][Full Text] [Related]
15. Heparanase expression is associated with histone modifications in glioblastoma.
Hong X; Nelson K; Lemke N; Kalkanis SN
Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
[TBL] [Abstract][Full Text] [Related]
17. Local depletion of DNA methylation identifies a repressive p53 regulatory region in the NEK2 promoter.
Nabilsi NH; Ryder DJ; Peraza-Penton AC; Poudyal R; Loose DS; Kladde MP
J Biol Chem; 2013 Dec; 288(50):35940-51. PubMed ID: 24163369
[TBL] [Abstract][Full Text] [Related]
18. Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells.
Gagnon J; Shaker S; Primeau M; Hurtubise A; Momparler RL
Anticancer Drugs; 2003 Mar; 14(3):193-202. PubMed ID: 12634613
[TBL] [Abstract][Full Text] [Related]
19. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
[TBL] [Abstract][Full Text] [Related]
20. [Activation of formylpeptide receptor in human malignant glioma cells and its effects on cell proliferation and production of angiogenic factors].
Yao XH; Bian XW; Ping YF; Chen JH; Wang QL; Jiang XF
Ai Zheng; 2007 Mar; 26(3):241-6. PubMed ID: 17355784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]